Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Aortic Neck Length, Angle Are Key Determinants Of Graft Success - Workshop

This article was originally published in The Gray Sheet

Executive Summary

Preclinical testing models for abdominal aortic aneurysm grafts could be enhanced by a better understanding of the unique morphologic and physiologic traits of the aneurysmal aorta, stent graft developers said during a July 31-Aug. 1 workshop.

You may also be interested in...



UK Medical Devices Agency Issues AAA, Breast Implant Device Updates

Endovascualar prosthesis treatment outcomes remain contingent on factors such as aneurysmal remodeling and patients' vascular anatomy, the UK's Medical Devices Agency concludes in a 1May update on devices for abdominal and thoracic aortic aneurysms

UK Medical Devices Agency Issues AAA, Breast Implant Device Updates

Endovascualar prosthesis treatment outcomes remain contingent on factors such as aneurysmal remodeling and patients' vascular anatomy, the UK's Medical Devices Agency concludes in a 1May update on devices for abdominal and thoracic aortic aneurysms

AAA Graft Pre-Clinical Workshop Input Could Be Included In ISO Standards

The International Organization for Standards (ISO) is considering pre-clinical testing standards for abdominal aortic anyeursm (AAA) endovascular grafts based on types of device failure identified in clinical studies and postmarket surveillance data.

Latest Headlines
See All
UsernamePublicRestriction

Register

MT015237

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel